To further support the specialty healthcare ecosystem, we’ve unlocked our technology to empower your brand’s HUB with real-time benefit investigation support and unbelievable results.

Biopharma companies face considerable challenges during the Annual Reverification (AR) season. Patient Services Programs often become overwhelmed by labor-intensive processes. To exacerbate the situation, current technology lacks the necessary flexibility and scalability, leading to delayed responses to providers and postponing patient treatments. Understanding the critical need to maintain patient access support for its life changing product, a biopharma company sought a solution to tackle these urgent challenges for the second consecutive year.